Used as a key intermediate in the synthesis of certain bioactive molecules, particularly in the development of peptidomimetic drugs. Its structure allows for selective interactions with enzyme active sites, making it valuable in designing inhibitors for proteases involved in disease pathways. The presence of the terminal alkene group enables further functionalization via click chemistry or cross-metathesis, facilitating conjugation to carriers or labeling with probes in medicinal chemistry research. It is also employed in the preparation of chiral building blocks for asymmetric synthesis.